ZNF268 and cervical carcinoma: ZNF268 is predicted to be a high affinity target of miR-1260b, with a target score of 100 (the maximum of target score) in the miRDB database (Chen and Wang, 2020), and is found to be overexpressed in cervical cancer (Wang et al., 2012) and ovarian carcinomas (Hu et al., 2013).